Learn more

GENOPROT CO LTD

Overview
  • Total Patents
    17
About

GENOPROT CO LTD has a total of 17 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are HENAN CENTER FOR ANIMAL DISEASE CONTROL & PREVENTION, KURODA MASAHIKO and SHANGHAI INST OF ENDOCRINE AND METABOLIC DISEASES.

Patent filings in countries

World map showing GENOPROT CO LTDs patent filings in countries

Patent filings per year

Chart showing GENOPROT CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Sung Chun 12
#2 Kim Gyu Chan 2
#3 Park Mi Hui 2
#4 Lee Seong Uk 2
#5 Kim Sung-Chun 2
#6 Hwang Hye Suk 2
#7 Kim Yeong Mi 1
#8 Jahng Deok Jin 1
#9 Sung-Chun Kim 1
#10 Lee Dong Hun 1

Latest patents

Publication Filing date Title
KR20080011856A Method for analysis of biological molecule using single-stranded nucleic acid aptamer and gold nano-particle
KR20070061970A Single-stranded nucleic acid aptamer specifically binding to serum protein
KR20070054485A Single-stranded nucleic acid aptamer specifically binding to foods-borne pathogen
KR20050106759A Method for identification and analysis of certain molecules using the dual function of single strand nucleic acid
KR20050095972A Method for identification and analysis of specific molecules using molecular beacons
KR100464225B1 Method for identification and analysis of specific molecules using single strand nucleic acid ligands
KR20040073030A Receptor for surface plasmon resonance sensor system
KR20040040889A Anticancer Agents Comprising Macrocyclic Peptide Compound and Method for Diagnosing Cancer
KR20040035248A Method for identification and analysis of certain molecules using single strand nucleic acid array and nucleic acid ligands to e. coli therefor
KR20040031405A Trans-Splicing Ribozyme Mediated Selective Induction of Gene Activity in Hepatitis C Virus Internal Ribosome Entry Site-Expressing Cells
WO02102400A1 Use of macrocyclic peptide compound as anticancer agents and method for diagnosing cancer
KR20030094519A Method for Assaying Functional Population Microorganism in Ecosystem, Oligonucleotide Chip and Base Sequence of Oligonucleotide
KR20010103809A Use of Thiostrepton as Anticancer Agents
KR20010106282A Use of Micrococcin as Anticancer Agents
KR20020014283A RNA Specifically Binding to Regulatory Protein for Hepatitis C Virus Proliferation and Method for Diagnosing HCV Infection Using Thereof